Riskpilot← Back to searchSign inGet full accessMYCARDIO ApS
APSActiveCVR 35664211Tryggehvile Alle 1Medical specialists activities · NACE 8622Est. 2014— employeeswww.karkirurgicph.dk
Revenue 2025
DKK 37K
-82% vs 2024
EBITDA margin
100.0%
-82% vs 2024
Equity ratio
49.0%
Financial strength
Net profit 2025
DKK 4,3M
+406% vs 2024
| Revenue | DKK 37K | -82% |
| EBITDA | DKK 37K | -82% |
| Net profit | DKK 4,3M | +406% |
| Total assets | DKK 9,1M | +37% |
| Equity | DKK 4,4M | +4% |
| Employees | — | — |
Legal name
MYCARDIO ApS
CVR number
35664211
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
14. februar 2014
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med lægelige og især karkirurgiske ydelser samt at øve konsulent- og rådgivningsvirksomhedsaktiviteter i tilknytning hertil.
Address
Tryggehvile Alle 1
Phone
+4551259039
Email
mlg@dadlnet.dk
Website
www.karkirurgicph.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 406 | 616 | 643 | 205 | 37 |
| Staff expenses | -3 | -5 | -5 | -0 | -0 |
| EBITDA | 402 | 611 | 638 | 205 | 37 |
| Depreciation & amort. | -79 | -76 | -41 | -41 | -41 |
| EBIT | 323 | 536 | 597 | 164 | -4 |
| Net financials | 118 | 51 | 870 | 903 | 4.376 |
| Profit before tax | 441 | 586 | 1.467 | 1.067 | 4.372 |
| Tax | 99 | 114 | 195 | 220 | 89 |
| Net profit | 342 | 473 | 1.272 | 847 | 4.283 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6.035 | 6.146 | 6.658 | 6.635 | 9.065 |
| Equity | 4.780 | 5.138 | 6.411 | 4.258 | 4.441 |
| Long-term debt | 29 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.226 | 1.008 | 247 | 2.377 | 4.624 |
| Total debt | 1.255 | 1.008 | 247 | 2.377 | 4.624 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20212025
Equity ratio
49.0%
This company
38.2%
Market median
+28% vs market
20212025
Return on equity
96.4%
This company
18.4%
Market median
+424% vs market
20212025
Net profit margin
11566.3%
This company
8.1%
Market median
+142694% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MM Chief Executive Officer | Chief Executive Officer | 2014 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mycardio Holding ApS
MYCARDIO ApS Board members of MYCARDIO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie-Louise Moes Struckmann | Chief Executive Officer | 0 companies |